HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Trolox on altered vasoregulatory gene expression in hepatic ischemia/reperfusion.

Abstract
This study was designed to investigate the effect of Trolox, a hydrophilic analogue of vitamin E, on the alteration of vasoregulatory gene expression during hepatic ischemia and reperfusion (I/R). Rats were subjected to 60 min of hepatic ischemia in vivo. The rats were treated intravenously with Trolox (2.5 mg/kg) or the vehicle as a control 5 min before reperfusion. Liver samples were obtained 5 h after reperfusion for a RT-PCR analysis on the mRNA for the genes of interest. These mRNA peptides are endothelin-1 (ET-1), potent vasoconstrictor peptide, its receptor ET(A) and ET(B), vasodilator endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), heme oxygenase-1 (HO-1), tumor necrosis factor-alpha (TNF-alpha) and cyclooxygenase-2 (COX-2). It was seen that serum alanine aminotransferase and lipid peroxidation levels were markedly increased after I/R and Trolox significantly suppressed this increase. In contrast, the glutathione concentration decreased in the I/R group, and this decrease was inhibited by Trolox. ET-1 mRNA expression was increased by I/R, an increase which was prevented by Trolox. The mRNA levels for ET(A) receptor was significantly decreased, whereas ET(B) receptor transcript increased in the I/R group. The increase in ET(A) was prevented by Trolox. The mRNA levels for iNOS and HO-1 significantly increased in the I/R group and Trolox attenuated this increase. There were no significant differences in eNOS mRNA expression among any of the experimental groups. The mRNA levels for COX-2 and TNF-alpha significantly increased in I/R group and Trolox also attenuated this increase. Our findings suggest that I/R induces an imbalanced hepatic vasoregulatory gene expression and Trolox ameliorates this change through its free radical scavenging activity.
AuthorsHyun-Ae Eum, Sun-Mee Lee
JournalArchives of pharmacal research (Arch Pharm Res) Vol. 27 Issue 2 Pg. 225-31 (Feb 2004) ISSN: 0253-6269 [Print] Korea (South)
PMID15022726 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromans
  • DNA Primers
  • Isoenzymes
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Alanine Transaminase
  • Glutathione
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Topics
  • Alanine Transaminase (metabolism)
  • Animals
  • Blood Vessels (physiology)
  • Chromans (pharmacology)
  • Cyclooxygenase 2
  • DNA Primers
  • Gene Expression Regulation (drug effects)
  • Glutathione (metabolism)
  • Isoenzymes (biosynthesis, genetics)
  • Lipid Peroxidation (drug effects)
  • Liver (drug effects, metabolism)
  • Male
  • Prostaglandin-Endoperoxide Synthases (biosynthesis, genetics)
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha (biosynthesis, genetics)
  • Vasoconstrictor Agents (metabolism)
  • Vasodilator Agents (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: